Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer

Additional biomarkers for the development and progression of colorectal cancer (CRC) remain to be identified. Hence, the current study aimed to identify potential diagnostic markers for CRC. Analyses of cysteine protease inhibitor [cystatins (CSTs)] expression in CRC samples and its correlation with...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qiurong, Liu, Liya, Chen, Xiaoping, Cheng, Ying, Li, Jiapeng, Zhang, Xiuli, Xu, Nanhui, Han, Yuying, Liu, Huixin, Wei, Lihui, Peng, Jun, Shen, Aling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317524/
https://www.ncbi.nlm.nih.gov/pubmed/34335931
http://dx.doi.org/10.7150/jca.53983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317524/
https://www.ncbi.nlm.nih.gov/pubmed/34335931
http://dx.doi.org/10.7150/jca.53983

Ejemplares similares